超声引导凝血酶注射治疗肾肝活检后出血
本研究描述经皮凝血酶注射至彩色多普勒超声识别的肝、肾活检通道浅表活动性出血部位的技术与结局。注射后15/16(94%)患者无需进一步干预。对于压迫观察≥30分钟后彩色多普勒仍见活动性出血者,该技术可有效终止出血。
要点
- 彩色多普勒超声可识别肝、肾活检通道浅表的活动性出血。
- 经皮凝血酶注射后94%(15/16)患者无需进一步干预。
- 压迫观察≥30分钟仍活动性出血者可考虑该技术。
关键影像表现/征象
- 彩色多普勒超声可识别肝、肾活检通道浅表的活动性出血。
诊断标准与关键数值
- 压迫观察≥30分钟后彩色多普勒仍见活动性出血,可考虑行超声引导凝血酶注射。
- 凝血酶注射后15/16(94%)患者无需进一步干预。
临床应用与阅片要点
- 对肝、肾活检后彩色多普勒显示活动性出血者,可将凝血酶注射至活检通道浅表出血部位。
- 操作前应先进行≥30分钟压迫观察,仍见活动性出血再考虑注射。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The purpose of this study was to describe the technique and outcomes of percutaneous thrombin injection into the superficial aspect of actively bleeding liver and kidney biopsy tracks identified with color Doppler ultrasound with the aim of hemorrhage termination. After percutaneous thrombin injection, 15/16 (94%) patients did not require further intervention. Ultrasound-guided thrombin injection into the superficial site of active bleeding is an effective technique for terminating bleeding in the immediate post-procedure period following kidney and liver biopsies and should be considered if active bleeding persists on color Doppler after ≥30 minutes of compression and observation.
引用
- Hoegger MJ, Middleton WD. Ultrasound-Guided Thrombin Injection for the Treatment of Bleeding Following Kidney and Liver Biopsies. J Ultrasound Med. 2021. PMID: 33780029. doi:10.1002/jum.15699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。